🇺🇸 FDA
Patent

US 7807174

Class of therapeutic protein based molecules

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7807174 (Class of therapeutic protein based molecules) held by United States of America/NIH expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America/NIH
Grant date
Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K39/00, A61P, A61P11/04